Consequently, numerous studies have indicated that SUSD3 could serve as a novel tumor marker, capable of predicting therapeutic outcomes and playing a pivotal role in forecasting both the prognosis of breast cancer and the efficacy of adjuvant therapies. The gene discussed is SUSD3; the disease is breast carcinoma.